Aims Our objective was to investigate whether alterations in endothelial Ca 2þ homeostasis contribute to the clinical toxicity of iodinated radiographic contrast media (IRCM) by modulating nitric oxide (NO) production and the endothelium-derived hyperpolarizing factor (EDHF) phenomenon.
Introduction
Contrast-induced nephropathy (CIN) is now cited as the third most common cause of new-onset renal failure in hospitalized patients and is therefore one of the major iatrogenic causes of morbidity/mortality associated with administration of iodinated radiographic contrast media (IRCM). [1] [2] [3] Indeed, in patients with co-existent diabetes, renal impairment and heart failure, the incidence CIN has been reported to be as high as 30-50%. [1] [2] [3] An understanding of underlying mechanisms may contribute to better guidance for clinicians on minimizing the occurrence of CIN while still conducting necessary procedures.
Several reports suggest that impaired endothelial NO production may contribute to the nephrotoxicity of IRCM. Inhibitors of endothelial NO synthase (eNOS) and IRCM may thus both predispose to tubular necrosis by impairing renal medullary blood flow in the rat, and the deleterious effect of IRCM on renal function may be ameliorated by L-arginine, the endogenous substrate for eNOS. [4] [5] [6] Furthermore, cascade bioassay techniques with isolated arteries have shown that IRCM inhibit endothelial NO release evoked by fluid shear stress, 7 and there is evidence that plasma levels of nitrite, the principal circulating metabolite of NO, are depressed following clinical angiography with IRCM. 8 The endothelium also promotes arterial relaxation through a hyperpolarizing mechanism that results in the closing of voltage-dependent L-type smooth muscle Ca 2þ channels. 9, 10 While numerous candidates have been advanced as freely diffusible endothelium-derived hyperpolarizing factors (EDHFs), none has consistently emerged as a mediator of hyperpolarization-dependent relaxation. 9, 10 Indeed, in rabbit arteries, NO-independent, 'EDHF-type' relaxations involve electrotonic spread of endothelial hyperpolarization through the vessel wall via gap junctions. [10] [11] [12] [13] This electrical mechanism acts synergistically with NO, with gap junction-dependent pathways dominating over NO-mediated vasodilatation in resistance arteries. 13 To our knowledge, no previous studies have investigated the effects of IRCM on EDHF-type responses.
In the present study we have therefore compared the effects of IRCM on NO-mediated and EDHF-type relaxations, postulating that such agents might impair endothelial function by modulating Ca 2þ homeostasis because eNOS is a Ca 2þ -dependent enzyme and the EDHF phenomenon is dependent on the opening of hyperpolarizing endothelial Ca 2þ -activated K þ channels (K Ca ). 9, 10 Two principal mechanisms are thought to underpin endothelium-dependent responses to agonists: (i) Ca 2þ release from the endoplasmic reticulum (ER) mediated by formation of inositol 1,4,5-trisphosphate (InsP 3 ) following activation of phospholipase C (PLC) by G proteins and (ii) store-operated Ca 2þ entry (SOCE) secondary to depletion of the ER Ca 2þ store. Inhibitors of the sarcoplasmic ER Ca 2þ -ATPase (SERCA), which deplete stores by preventing ER Ca 2þ uptake, are thus able to stimulate NO synthesis and EDHF-type responses independently of PLC. 14, 15 We first investigated the effects of iohexol and the osmotic agent mannitol on SOCE in rabbit aortic valve (RAV) leaflets incubated with the SERCA inhibitor cyclopiazonic acid (CPA) using a standard Ca 2þ re-entry protocol. This comparison is important because the high osmolarities of some IRCM have often been assumed to underpin their propensity to cause CIN. [1] [2] [3] We subsequently investigated the effects of iohexol on the assembly of store-operated Ca 2þ channels (SOCs) using immunohistochemistry of the RAV to detect clustering of Orai1, the membrane protein now recognized as the critical pore component of the Ca 2þ release-activated Ca 2þ channel (CRAC). [16] [17] [18] [19] [20] Depletion of the ER store promotes loss of bound Ca 2þ from the luminal N-terminus EF-hand motif of the ER Ca 2þ sensing protein STIM1 (Stromal Interaction Molecule 1), resulting in oligomerization of Orai1 and STIM1 in puncta at ER-plasmalemmal junctions to form the complexes that underpin SOCE in many cell types, including endothelium. 16, 17 Ca 2þ re-entry experiments were also performed to evaluate the possible contribution of osmosensor transient receptor potential vanilloid type 4 channels (TRPV4) [21] [22] [23] and connexin hemichannels [24] [25] [26] to SOCE in the RAV endothelium. Finally, rabbit iliac artery (RIA) rings were used to compare the effects of two clinically used non-ionic IRCM, iohexol and iodixanol, on NO-mediated and EDHF-type relaxations evoked by CPA and the prototype endotheliumdependent agonist acetylcholine (ACh) in order to dissociate the contributions of SOCE and InsP 3 -mediated Ca 2þ release to endothelium-dependent relaxation. Since iohexol is a triiodinated monomer and iodixanol is a hexaiodinated dimer, evaluation of these two classes of IRCM allowed the effects of iodine concentration and molarity on endothelium-dependent relaxation and intrinsic smooth muscle function to be differentiated.
Methods

Tissues
Experiments were performed with aortic valve leaflets and iliac arteries obtained from male New Zealand White rabbits (2-2.5 kg) killed with sodium pentobarbitone (120 mg/kg i. 
RAV endothelium
Rabbit aortic valve leaflets were loaded with 2 mM Fluo-4 AM or 5 mM Fura-2 AM for 2 h in oxygenated Holmans buffer at room temperature. 27 Following incubation in nominally Ca ) and 2-aminoethoxydiphenyl borate (2-APB), the TRPV4 channel modulators 4a-phorbol-12,13-didecanoate (4a-PDD) and ruthenium red (RuR), and the hemichannel blockers niflumic acid (NFA) and carbenoxolone. The effects of 4a-PDD and RuR on basal [Ca 2þ ] i were also evaluated in the presence of normal extracellular [Ca 2þ ]. Experiments were performed in the presence of 300 mM nitro-L-arginine methylester (L-NAME) to inhibit eNOS and 10 mM indomethacin to inhibit prostanoid formation by cyclooxygenases (COX-1 and COX-2), except where indicated.
Immunohistochemistry
Rabbit aortic valve leaflets were incubated with L-NAME/indomethacin in normal [Ca 2þ ] buffer or Ca 2þ -free buffer containing 30 mM CPA to induce store depletion in order to investigate the effects of iohexol on membrane clustering of Orai1. Staining was performed on 2% paraformaldehyde-fixed tissue initially incubated with an Fc receptor blocker (Innovex) for 30 min, then with blocking solution containing BSA and donkey serum in PBS. Leaflets were then incubated overnight with rabbit anti-human Orai1 antibody (1:00 dilution, Alomone) followed by 2 h incubation with Cy5-conjugated donkey anti-rabbit secondary antibody (1:100 dilution, Jackson ImmunoResearch Laboratories). Leaflets were imaged at 633 nm using a Leica RS2 confocal microscope. Control sections showed no staining in the absence of primary antibody.
Mechanical experiments
Rings (2-3 mm wide) were mounted in a myograph (model 610M; Danish MyoTechnology, Aarhus) containing oxygenated buffer at 378C, placed under a resting tension of 2 mN, and allowed to equilibrate for 30 min with readjustments of tension to compensate for stress relaxation. The effects of preincubation with 90 mg I/mL iohexol or iodixanol were examined for their ability to modulate contractile responses to 1 mM phenylephrine (PE) and relaxations subsequently evoked by CPA or ACh. Experiments were performed in the presence and absence of L-NAME/ indomethacin to study EDHF-type responses and relaxations mediated by combined NO-dependent and -independent mechanisms, except in a subset of experiments where indomethacin was administered in the absence of L-NAME. Maximal percentage reversal of PE-induced constriction (R max ) and concentrations giving 50% reversal of this constrictor response (IC 50 for CPA) or 50% of maximal relaxation (EC 50 for ACh) were determined for each experiment. The use of IC 50 was necessary to allow for a small initial CPA-evoked constriction which is likely to reflect smooth muscle SERCA blockade. 27 The role of PLC in ACh-evoked relaxations was investigated with the inhibitor 1-(6-[(17b-3-methoxyestra-1,3,5(10)-triene-17-yl)amino]hexyl)-1H-pyrrole-2,5-dione (U73122). We also investigated whether 4a-PDD induced endothelium-dependent relaxation, as reported in rat arteries. 21, 22 In a subset of experiments, rings were denuded of endothelium to assess the effects of IRCM on relaxation evoked by the NO donors (
and sodium nitroprusside (SNP).
Reagents
Drugs were obtained from SigmaGenosys except Fluo-4 AM and Fura-2 AM (Invitrogen), 2-APB (Calbiochem) and pure iohexol/iodixanol (GE Healthcare). Stock solutions were prepared in buffer with the exception of CPA, NFA, 4a-PDD and U73122 (DMSO), indomethacin and 2-APB (ethanol), EGTA (NaOH), and GdCl 3 and CaCl 2 (dH 2 O).
Statistics
Statistical differences were assessed by the Student non-paired t-test or one-way ANOVA followed by Tukey's post hoc test. Data are presented as mean + SEM, where n denotes the number of animals studied for each data point. P , 0.05 was considered significant.
Results
RAV endothelium 3.1.1 Fluo-4 experiments
Readmission of Ca 2þ in RAV leaflets preincubated with 30 mM CPA in Ca 2þ -free buffer evoked a rise in endothelial [Ca 2þ ] i that attained a plateau within 5 min and was progressively reduced by 30 and 90 mg I/mL iohexol, but unaffected by mannitol at 236.4 mM, which is equivalent to the molarity of 90 mg I/mL iohexol ( Figure 1 ).
Fura-2 experiments
This ratiometric technique generally demonstrated a rise in endothelial [Ca 2þ ] i over 1 min followed by a fall to a plateau over 5 min. Ca 2þ re-entry was attenuated by 100 mM Gd 3þ and 100 mM 2-APB (Figure 2A-C) . Neither SOCE nor basal [Ca 2þ ] i were affected by 4a-PDD or RuR, which, respectively, activate and inhibit osmosensor TRPV4 channels ( Figure 2D and E). Connexin hemichannels can reportedly mediate Ca 2þ influx in cells exposed to Ca 2þ -free buffer, but neither 100 mM NFA nor 300 mM carbenoxolone, which block this influx pathway, affected SOCE ( Figure 2F) . No difference in SOCE was apparent in leaflets incubated in the absence of L-NAME/indomethacin ( Figure 2F ).
Immunohistochemistry
In RAV leaflets incubated with normal extracellular [Ca 2þ ] staining for Orai1 was diffuse, whereas discrete puncta became evident following store depletion with 30 mM CPA in valves incubated in Ca 2þ -free buffer ( Figure 3) . Clustering was not suppressed by preincubation with 90 mg I/mL iohexol.
RIA rings 3.2.1 Constrictor responses
In endothelium-intact rings, 90 mg I/mL iohexol reduced force development to PE by 30%, whereas a small reduction apparent with 90 mg I/mL iodixanol failed to achieve significance ( Table 1) . Constrictor responses were unaffected by indomethacin alone but enhanced by L-NAME/indomethacin ( Table 1) .
Relaxant responses 3.2.2.1 CPA
Relaxation was generally sustained, with control responses exhibiting a significant rightward shift in the presence of L-NAME/indomethacin without change in an R max that was 90% of the constrictor response to PE ( Figure 4A -C, Table 2 ). Incubation with 90 mg I/mL iohexol or iodixanol caused rightward shifts in the concentration-response curves for both EDHF-type and combined EDHF-type/NO relaxations to statistically similar pIC 50 values, with small reductions in R max achieving significance only with iohexol ( Figure 4B and C; Table 2 ). Incubation with indomethacin alone did not modify concentration-relaxation curves constructed in the presence or absence of 90 mg I/mL iohexol or iodixanol ( Table 2 ).
Acetylcholine
EDHF-type relaxations were generally transient, so that successive concentrations of ACh were administered as relaxation waned and responses quantified as the peak relaxation observed after each successive intervention ( Figure 4D ). In the presence of L-NAME/indomethacin, concentration-relaxation curves exhibited a maximal response equivalent to 65% of PE-evoked tension, and were unaffected by 90 mg I/mL iohexol or iodixanol ( Figure 4E , Table 2 ). In the absence of L-NAME/indomethacin, ACh-evoked relaxations were more sustained and maximally attained 90% of PE-evoked tension, and were unaffected by iodixanol, but attenuated by iohexol ( Figure 4F , Table 2 ). Indomethacin alone did not affect concentrationrelaxation curves constructed in the presence or absence of 90 mg I/mL iohexol or iodixanol ( Table 2 ). , and also demonstrating no effect of NFA, carbenoxolone, or omission of L-NAME/indomethacin from the buffer. *P , 0.05 compared with control; n ¼ 3-9.
The PLC inhibitor U-73122 (1 mM) markedly reduced ACh-evoked relaxations both in the presence and in the absence of L-NAME/indomethacin (Figure 5A and B; Table 3 ).
3.2.2.3 4a-Phorbol-12,13-didecanoate 4a-Phorbol-12,13-didecanoate failed to induce relaxation in preconstricted endothelium-intact rings over the range 0.01-10 mM (n ¼ 3, data not shown).
Exogenous NO
In endothelium-denuded rings, 90 mg I/mL iohexol attenuated the smooth muscle relaxant response to exogenous NO, administered as MAHMA NONOate or SNP, whereas iodixanol was without effect (Figure 5C and D; Table 3 ).
Discussion
The major finding of the present study is that IRCM can impair SOCE in endothelial cells. This previously unrecognized action of these iodine-based compounds may contribute to their vascular activity through global inhibition of endothelium-dependent relaxation.
Iohexol caused concentration-dependent reductions in Ca 2þ re-entry in the endothelium of RAV leaflets incubated with 30 mM CPA in Ca 2þ -free buffer, and their effects were mimicked by Gd 3þ ions and 2-APB, which are established inhibitors of SOCE in endothelial cells. 16 Immunohistochemistry demonstrated that the CRAC protein Orai1 clustered in puncta in the membrane of RAV endothelial cells following Ca 2þ store depletion. Such structures mark the sites where Orai1 co-localizes with STIM1 to form the complexes that are now thought to mediate endothelial SOCE. 16, 17 The finding that Orai1 clustering was unaffected by iohexol at a concentration that markedly attenuated Ca 2þ re-entry (90 mg I/mL, which approximates the peak iodine concentration achieved during clinical angiography) is consistent with the hypothesis that IRCM impede the influx of Ca 2þ ions through SOCs, rather than prevent their assembly, because IRCM are unable to cross the cell membrane under normal conditions. 28 The possibility that Ca 2þ re-entry was mediated by connexin hemichannels, which reportedly allow Ca 2þ influx in cultured cell systems exposed to Ca 2þ -free buffer, was excluded by the demonstration that hemichannel blockade by niflumic acid or carbenoxolone [24] [25] [26] did not modify SOCE in freshly isolated RAV leaflets. Omission of L-NAME from the incubation medium did not modify Ca 2þ re-entry in RAV leaflets, indicating that endogenously generated NO is not a major determinant of SOCE in rabbit endothelium, even though it reportedly accelerates SERCA-mediated Ca 2þ sequestration and inhibits SOC channels. [29] [30] [31] The inhibitory effects of iohexol on Ca 2þ re-entry in RAV leaflets but insensitivity to the osmotic agent mannitol suggests that the presence of organically bound iodine, rather than osmolarity, may underpin the loss of SOCE. Indeed, Ca 2þ re-entry was completely unaffected by mannitol at a molarity equivalent to that of 90 mg I/mL iohexol. We also excluded the possibility that IRCM modulate the activity of osmosensing, volume-regulated TRPV4 Ca 2þ influx channels using 4a-PDD and RuR, which, respectively, activate and inhibit such channels. [21] [22] [23] Neither agent affected basal [Ca 2þ ] i in RAV leaflets incubated in normal [Ca 2þ ] buffer or Ca 2þ re-entry under Ca 2þ -free conditions, and 4a-PDD failed to evoke endothelium-dependent relaxation in RIA rings. This contrasts with certain rat arteries in which the endothelium expresses TRPV4, and 4a-PDD induces robust elevations in [Ca 2þ ] i that promote RuR- Experiments were performed in the presence or absence of L-NAME and indomethacin as indicated.
*P , 0.05: significantly different from control.
sensitive, endothelium-dependent relaxations that involve both NO and EDHF-type mechanisms. 21, 22 Further evidence for the role of iodine was obtained in mechanical experiments in which CPA-evoked relaxations of RIA rings were depressed to a similar extent by incubation with the monomer iohexol or the dimer iodixanol at 90 mg I/mL despite an 2-fold difference in molarity. Concentration-relaxation curves exhibited larger rightward shifts in the absence of L-NAME, consistent with dual inhibition of NO and EDHF-type mechanisms by the IRCM, and small reductions in maximal relaxation were also evident, although these were significant only with iohexol. Neither IRCM affected ACh-evoked, EDHF-type relaxations, and relaxations to ACh involving both NO and EDHF-type mechanisms were unaffected by iodixanol, but reduced by iohexol. Experiments with MAHMA NONOate and SNP in endothelium-denuded RIA rings indicated that this differential activity was attributable to an ability of iohexol, but not iodixanol, to depress the direct smooth muscle relaxant response to NO under the experimental conditions employed. Differential inhibition of CPA-and ACh-evoked responses indicates that IRCM do not suppress the opening of the hyperpolarizing endothelial K Ca channels that initiate the EDHF phenomenon and, further, that they do not interrupt the subsequent electrotonic spread of this hyperpolarizing response, because blockade of gap junctions impairs both CPA-and ACh-evoked EDHF-type relaxations in the RIA. [10] [11] [12] 27, 31 Complicating effects of endothelium-derived prostanoids such as PGI 2 or PGF 2a , which might respectively enhance or oppose relaxation, 32 were excluded by the demonstration that concentration-relaxation curves for CPA and ACh were unaffected by inclusion of indomethacin in the buffer in the absence of L-NAME. Experiments were performed in the presence or absence of L-NAME and indomethacin as indicated. Potency (negative log molar IC 50 or EC 50 ) and maximal percentage relaxation (R max ) are expressed as mean + SEM. *P , 0.05: significantly different from control. † P , 0.05: significantly different from all other groups. 20, 33, 35, 36 and iohexol was without effect on Orai1 clustering in the RAV. It has been suggested that TRPC1 channels contribute to endothelial Ca 2þ homeostasis by functioning as receptor-operated channels (ROCs) that are coupled to the InsP 3 cascade but are insensitive to store depletion. 33 In theory, this alternative Ca 2þ influx pathway could contribute to the insensitivity of ACh-evoked relaxations to the IRCM. However, there is evidence that following depletion of the ER Ca 2þ store Orai1 promotes an interaction between STIM1 and TRPC1 that results in the insertion of TRPC1 into lipid rafts, where it may then function as integral component of the SOC complex, rather than a ROC. 20, 33, 35, 36 Both IRCM reduced the magnitude of the contractile response to PE in the RIA when applied at 90 mg I/mL, although this reduction was significant only in the case of iohexol. This is consistent with previous studies in rabbit aorta, demonstrating that the ability of IRCM to impair PE-induced constriction correlates with applied molarity, rather than iodine concentration, and is therefore more pronounced with monomeric than dimeric agents. 37, 38 Indeed, pharmacological analysis has also demonstrated that IRCM perturb multiple mechanisms involved in smooth muscle ion homeostasis and contraction, including the Na þ -K þ ATPase, K Ca channels, Na þ -Ca 2þ exchange and Na þ -H þ exchange, and that the effects of IRCM on these transport systems are more evident with iohexol than iodixanol. 37, 38 The pathways through which IRCM attenuate NO-mediated smooth muscle relaxation directly remain to be established, although a role for osmolarity is suggested by observations that mannitol attenuates relaxation to SNP, 37,38 thus contrasting with its lack of effect on SOCE in the RAV endothelium.
The present findings may have important clinical implications. In animal models of CIN, IRCM, and inhibitors of eNOS rapidly impair renal medullary perfusion (within 10 min), thus suggesting that endothelium-dependent mechanisms contribute to the viability of renal tubules, which have high metabolic requirements despite existing in a relatively hypoxic microenvironment. [4] [5] [6] Since the EDHF phenomenon is widely thought to compensate for the depressed NO bioavailability that characterizes disease states such as diabetes and heart failure, 9,10 the present demonstration that IRCM depress both NO-dependent and NO-independent endothelium-dependent responses may help explain why IRCM are particularly detrimental in patients with these conditions. [1] [2] [3] Indeed, in some models of diabetes, EDHF-type relaxations may themselves be depressed as a consequence of impaired connexin expression and gap junction functionality. 39, 40 The toxicity of some IRCM may also be enhanced in patients with preexisting renal impairment, which is a particular risk factor for CIN, and speculatively this might reflect more prolonged intravascular residence of IRCM. The demonstration that adverse endothelial effects of IRCM appear to correlate with iodine concentration may therefore explain why monomeric and dimeric IRCM are associated with a similar incidence of CIN in normal subjects, despite their different osmolarities. [1] [2] [3] The balance between competing mechanisms may, however, differ in patients with alreadycompromised endothelial function, e.g. in diabetes, where the more pronounced direct smooth muscle effects of monomeric IRCM against direct NO-dependent relaxation might amplify their adverse effects on endothelial function.
Fluid shear stress is arguably the main physiological stimulus to the endothelium in vivo, and IRCM have been shown to impair shear-induced NO production in bioassay studies. 7 Shear stress also activates K Ca channel-dependent hyperpolarizing mechanisms that participate in endotheliumdependent dilatations evoked by flow. 41 Indeed, in vivo blockade of gap junctions with connexin-mimetic peptides has provided evidence that tonic EDHF-type activity may contribute to the maintenance of basal perfusion in the rat kidney. 42 Nevertheless, the relationship between the filling status of the ER Ca 2þ store and shear-induced Ca 2þ mobilization remains to be fully defined in the context of NO production and endothelium-dependent smooth muscle hyperpolarization. 7, 15, 43 Since other studies have suggested that the EDHF phenomenon does not contribute to basal tone but makes an appreciable contribution to stimulated hyperemia, [44] [45] [46] in vivo investigations of the interplay between the endothelial and smooth muscle effects of IRCM will therefore be important in providing further insights into the genesis of CIN.
In conclusion, iodixanol and iohexol both appear to impair endothelial-dependent relaxation, without modulating receptor-linked InsP 3 signalling directly. Loss of SOCE may reflect the presence of the iodine atom and reduced influx of Ca 2þ ions through SOCs.
